These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35039162)

  • 21. Triglyceride and Triglyceride/ HDL (High Density Lipoprotein) Ratio Predict Major Adverse Cardiovascular Outcomes in Women With Non-Obstructive Coronary Artery Disease.
    Prasad M; Sara J; Widmer RJ; Lennon R; Lerman LO; Lerman A
    J Am Heart Assoc; 2019 May; 8(9):e009442. PubMed ID: 31014162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.
    Rong S; Li B; Chen L; Sun Y; Du Y; Liu B; Robinson JG; Bao W
    J Am Heart Assoc; 2022 Aug; 11(15):e023690. PubMed ID: 35904192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women.
    Faaborg-Andersen CC; Liu C; Subramaniyam V; Desai SR; Sun YV; Wilson PWF; Sperling LS; Quyyumi AA
    Eur J Prev Cardiol; 2023 Mar; 30(4):293-304. PubMed ID: 36351048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
    Liao KP; Liu J; Lu B; Solomon DH; Kim SC
    Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
    Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
    Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum low-density lipoprotein to high-density lipoprotein ratio as a predictor of future acute myocardial infarction among men in a 2.7-year cohort study of a Japanese northern rural population.
    Yokokawa H; Yasumura S; Tanno K; Ohsawa M; Onoda T; Itai K; Sakata K; Kawamura K; Tanaka F; Yoshida Y; Nakamura M; Terayama Y; Ogawa A; Okayama A
    J Atheroscler Thromb; 2011; 18(2):89-98. PubMed ID: 20972352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Triglyceride to high-density lipoprotein cholesterol ratio and incident of diabetes mellitus: a secondary retrospective analysis based on a Chinese cohort study.
    Chen Z; Hu H; Chen M; Luo X; Yao W; Liang Q; Yang F; Wang X
    Lipids Health Dis; 2020 Mar; 19(1):33. PubMed ID: 32131838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
    van de Woestijne AP; van der Graaf Y; Liem AH; Cramer MJ; Westerink J; Visseren FL;
    J Am Coll Cardiol; 2013 Nov; 62(20):1834-41. PubMed ID: 23948286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
    Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
    JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.
    Hirata T; Sugiyama D; Nagasawa SY; Murakami Y; Saitoh S; Okayama A; Iso H; Irie F; Sairenchi T; Miyamoto Y; Yamada M; Ishikawa S; Miura K; Ueshima H; Okamura T;
    Eur J Epidemiol; 2017 Jul; 32(7):547-557. PubMed ID: 27709448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE).
    Bittner V; Johnson BD; Zineh I; Rogers WJ; Vido D; Marroquin OC; Bairey-Merz CN; Sopko G
    Am Heart J; 2009 Mar; 157(3):548-55. PubMed ID: 19249427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Hovingh GK; Mora S; Pedersen TR; Larosa JC; Welch KM; Amarenco P; Demicco DA; Tonkin AM; Sullivan DR; Kirby A; Colhoun HM; Hitman GA; Betteridge DJ; Durrington PN; Clearfield MB; Downs JR; Gotto AM; Ridker PM; Kastelein JJ
    Circulation; 2013 Oct; 128(14):1504-12. PubMed ID: 23965489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
    Weverling-Rijnsburger AW; Jonkers IJ; van Exel E; Gussekloo J; Westendorp RG
    Arch Intern Med; 2003 Jul; 163(13):1549-54. PubMed ID: 12860577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
    Hsu WH; Lai CW; Chen SC; Chiou HC; Hsiao PJ; Shin SJ; Lee MY
    Endocr Pract; 2019 Sep; 25(9):918-925. PubMed ID: 31070951
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.